MetaOptima Raises $8.6 Million to Detect Skin Cancer with AI

A healthtech company using AI to digitize the diagnosis system has raised a new funding round. MetaOptima Technology has raised $8.6 million to grow its cutting-edge DermEngine platform. The Series A round was led by the Australian Skip Capital and AirTree Ventures, with respective fund principals Scott Farquhar and Daniel Petre joining the MetaOptima board. "Our vision is bold: we want to be in every major dermatology centre and skin cancer clinic in Australia, and we're well on track to making that a reality," said Maryam Sadeghi, CEO and co-founder of MetaOptima. "With the support of AirTree Ventures and Skip Capital, we're confident our platform will continue to shape and change the state of play for both healthcare professionals and patients."